A detailed history of Bank Of America Corp transactions in Protalix Bio Therapeutics, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 44,994 shares of PLX stock, worth $76,489. This represents 0.0% of its overall portfolio holdings.

Number of Shares
44,994
Previous 111,164 59.52%
Holding current value
$76,489
Previous $130,000 65.38%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$0.9 - $1.17 $59,553 - $77,418
-66,170 Reduced 59.52%
44,994 $45,000
Q2 2024

Aug 14, 2024

SELL
$1.1 - $1.32 $3,735 - $4,482
-3,396 Reduced 2.96%
111,164 $130,000
Q1 2024

May 15, 2024

SELL
$1.22 - $1.82 $108,040 - $161,175
-88,558 Reduced 43.6%
114,560 $144,000
Q4 2023

Feb 14, 2024

BUY
$1.34 - $1.85 $177,354 - $244,854
132,354 Added 187.04%
203,118 $361,000
Q2 2023

Aug 14, 2023

BUY
$2.0 - $3.36 $141,450 - $237,636
70,725 Added 181346.16%
70,764 $141,000
Q1 2023

May 12, 2023

SELL
$1.37 - $2.16 $4,011 - $6,324
-2,928 Reduced 98.69%
39 $0
Q4 2022

Feb 10, 2023

SELL
$1.0 - $1.37 $60 - $82
-60 Reduced 1.98%
2,967 $4,000
Q3 2022

Nov 14, 2022

SELL
$1.03 - $1.24 $491 - $591
-477 Reduced 13.61%
3,027 $3,000
Q2 2022

Aug 12, 2022

SELL
$1.02 - $1.56 $1,681 - $2,572
-1,649 Reduced 32.0%
3,504 $3,000
Q1 2022

May 16, 2022

SELL
$0.81 - $1.17 $9,909 - $14,313
-12,234 Reduced 70.36%
5,153 $5,000
Q4 2021

Feb 08, 2022

BUY
$0.81 - $1.33 $6,882 - $11,301
8,497 Added 95.58%
17,387 $14,000
Q3 2021

Nov 15, 2021

BUY
$1.31 - $1.87 $3,952 - $5,641
3,017 Added 51.37%
8,890 $12,000
Q2 2021

Sep 13, 2021

BUY
$1.86 - $6.22 $10,923 - $36,530
5,873 New
5,873 $11,000

Others Institutions Holding PLX

About Protalix BioTherapeutics, Inc.


  • Ticker PLX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,753,400
  • Market Cap $84.6M
  • Description
  • Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso fo...
More about PLX
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.